Impact of the SARS-CoV-2 (COVID-19) Pandemic on Characteristics and Management of Uveal Melanoma in the National Referral Center in Poland.
In: Cancers, Jg. 16 (2024-06-01), Heft 11, S. 2061-2070
Online
academicJournal
Zugriff:
Simple Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(COVID-19) has been reported in China since December 2019, and the global outbreak began in early 2020, with the first lockdowns in Europe implemented in February 2020. Restrictions taken to limit the exposure of patients to virus contagion had a notable impact for non-COVID-19 pathologies, including eye cancers. Despite the fact that uveal melanoma is the most common primary intraocular cancer in adults, the number of publications on the impact of the COVID-19 pandemic on the characteristics and treatment of uveal melanoma is limited, and most of them have included small patient samples. We studied the impact of the COVID-19 pandemic on the characteristics and management of uveal melanoma (UM) in a group of 1336 patients from the National Referral Center in Poland. (1) Background: to analyze the impact of the COVID-19 pandemic on the characteristics and management of uveal melanoma (UM) in the National Referral Center in Poland. (2) Materials and Methods: the retrospective analysis of 1336 patients who were newly diagnosed with UM at the Department of Ophthalmology and Ophthalmic Oncology, Jagiellonian University Collegium Medicum Krakow, Poland between 1 January 2018 and 31 December 2021. The demographic and clinical data were compiled, including localization, size, and treatment methods of tumors. (3) Results: In total, 728 patients with UM were included before the COVID-19 pandemic, in the years 2018–2019, and 608 were included during the COVID-19 pandemic, in the years 2020–2021. Fixed-base dynamics indicators for the incidence of uveal melanoma (base year 2018) in the National Referral Center in Poland were 80.22% and 86.81% in the years 2020 and 2021, respectively. UMs were statistically significantly larger and more frequently localized anterior to the equator of the eye globe in the year 2021 than in the year 2018 (Chi-square Pearson test p = 0.0001 and p = 0.0077, respectively). The rate of patients treated with enucleation increased from 15.94% in the year 2018 to 26.90% in the year 2021 (Chi-square Pearson test p = 0.0005). (4) Conclusions: Statistically significant differences were found in the management of uveal melanoma in the National Referral Center in Poland during the COVID-19 pandemic with tumors being larger, more frequently localized anterior to the equator of the eye globe, and more often enucleated. [ABSTRACT FROM AUTHOR]
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Impact of the SARS-CoV-2 (COVID-19) Pandemic on Characteristics and Management of Uveal Melanoma in the National Referral Center in Poland.
|
---|---|
Autor/in / Beteiligte Person: | Romanowska-Dixon, Bożena ; Nowak, Michał Szymon ; Śmigielski, Janusz ; Dębicka-Kumela, Magdalena |
Link: | |
Zeitschrift: | Cancers, Jg. 16 (2024-06-01), Heft 11, S. 2061-2070 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 2072-6694 (print) |
DOI: | 10.3390/cancers16112061 |
Schlagwort: |
|
Sonstiges: |
|